Changing Pragmatics of The Indian Pharmaceutical Industry In The Pre and Post TRIPS Period

Ravi Kiran

Abstract


The agreement on Trade-Related Aspects of Intellectual Property-Rights (TRIPS) is an international treaty by the world trade organisation (WTO) which sets down minimum standards for most form of intellectual property (IP) regulation within all member countries of the world trade organization. As a result of TRIPS the Pharmaceutical industry has witnessed significant changes. Against this background, the paper tries to study the Post TRIPS Patenting, Exports and R& D Scenario in Pharmaceutical Industry of India. The study uses the primary as well as secondary data to the changes in the pharmaceutical industry in post-TRIPS period. There has been a paradigm shift in the policies and programs governing Indian pharmaceutical industry. The results of the study highlight that the new patent regime has encouraged innovation and greater investment in R&D. Patents are the most efficacious and indispensable tool to secure strategic competitive advantage in the market. The impact of TRIPS compliance is becoming increasingly visible, on the pharmaceutical industry in India.

 

Keywords: Trade-Related Aspects of intellectual property-Rights, General Agreement on Trade and Tariff, World Trade Organisation


Full Text: PDF DOI: 10.5539/ijbm.v4n9p206

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

International Journal of Business and Management   ISSN 1833-3850 (Print)   ISSN 1833-8119 (Online)

Copyright © Canadian Center of Science and Education

To make sure that you can receive messages from us, please add the 'ccsenet.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.